Wei Li

6PUBLICATIONS
91CO-AUTHORS
Molecular targetsMajor global burdens of diseasePhylogeny and comparative analysisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 13, 2026
IL1RAP Antibody-Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers.

Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang

|Feb 04, 2026
Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor.

Seungmin Shin, Yae-Jin Kim, Bernard J C Macatangay

|Oct 09, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.

Brian Mooney, Gian Luca Negri, Taras Shyp

|Jul 25, 2022
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Peter M Sullivan, Rajesh Kumar, Wei Li

|Apr 29, 2021
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.

Xing Zhu, Dhiraj Mannar, Shanti S Srivastava

|Nov 03, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.

Wei Li, Chuan Chen, Aleksandra Drelich

Pageof 1

Frequent Collaborators

6 joint publications

Dimiter S Dimitrov

2 joint publications

Hai-Feng Zhang

2 joint publications

Seungmin Shin

2 joint publications

Melanie Rouleau